Plasminogen and PAI-1 activators in tissues of adenocarcinoma and squamous cell carcinoma of the esophagus
- 作者: Kit O.1, Kolesnikov E.1, Frantsiyants E.1, Kozlova L.1, Pogorelova Y.1, Cheryarina N.1, Chugunova N.1
-
隶属关系:
- Rostov Research Institute of Oncology
- 期: 卷 21, 编号 4 (2016)
- 页面: 201-206
- 栏目: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40322
- DOI: https://doi.org/10.18821/10289984-2016-21-4-201-206
- ID: 40322
如何引用文章
全文:
详细
作者简介
O. Kit
Rostov Research Institute of OncologyRostov-on-Don, 344037, Russian Federation
E. Kolesnikov
Rostov Research Institute of OncologyRostov-on-Don, 344037, Russian Federation
E. Frantsiyants
Rostov Research Institute of OncologyRostov-on-Don, 344037, Russian Federation
Larisa Kozlova
Rostov Research Institute of Oncology
Email: 79094277471@yandex.ru
MD, PhD, associate professor, senior researcher of the hormonal laboratory Rostov-on-Don, 344037, Russian Federation
Yu. Pogorelova
Rostov Research Institute of OncologyRostov-on-Don, 344037, Russian Federation
N. Cheryarina
Rostov Research Institute of OncologyRostov-on-Don, 344037, Russian Federation
N. Chugunova
Rostov Research Institute of OncologyRostov-on-Don, 344037, Russian Federation
参考
- Masson V. Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis. Bull. Mem. Acad. Roy. Med. Belg. 2006; 161(5): 320-6.
- Айсина Р.Б., Мухаметова Л.И. Структура и функции системы плазминоге/плазмин. Биоорганическая химия. 2014; 40(6): 642-57. Review. Russian.
- Asuthkar S., Stepanova V., Lebedeva T., Holterman A.L., Estes N., Cines D.B. et al. Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer. Mol. Biol. Cell. 2013; 24(17): 2620-32.
- Witzel I., Milde-Langosch K., Schmidt M., Karn T., Becker S., Wirtz R. et al. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer. Onco Targets Ther. 2014; 7: 2205-13.
- Huang C., Xie D., Cui J., Li Q., Gao Y., Xie K. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system. Clin. Cancer Res. 2014; 20(6): 1477-88.
- Gong L., Liu M., Zeng T., Shi X., Yuan C., Andreasen P.A. et al. Crystal structure of the Michaelis complex between tissue-type plasminogen activator and plasminogen activators inhibitor-1. J. Biol. Chem. 2015; 290(43): 25795-804.
- Jiang W.G., Sanders A.J., Katoh M., Ungefroren H. et al. Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Semin. Cancer Biol. 2015; 244-75.
- McMahon B.J., Kwaan H.C. Components of the plasminogenplasmin system as biologic markers for cancer. Adv. Exp. Med. Biol. 2015; 867: 145-56.
- Fontanil T., Mohamedi Y., Esteban M.M., Obaya A.J., Cal S. Polyserase-1/TMPRSS9 induces pro-tumor effects in pancreatic cancer cells by activation of pro-uPA. Oncol. Rep. 2014; 31(6): 2792-6.
- Halámková J., Kiss I., Tomášek J., Pavlovský Z., Tuček S., Penka M. Significance of urokinase and its inhibitors in the invasiveness and metastasing of malignant tumors. Vnitr. Lek. 2012; 58(2): 129-34.
- Suh Y.S., Yu J., Kim B.C., Choi B., Han T.S., Ahn H.S. et al. Overexpression of plasminogen activator inhibitor-1 in advanced gastric cancer with aggressive lymph node metastasis. Cancer Res. Treat. 2015; 47(4): 718-26.
- Yamashita D., Kondo T., Ohue S., Takahashi H., Ishikawa M., Matoba R. et al. miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator. Cancer Res. 2015; 75(6): 1123-33.
- Qureshi T., Goswami S., McClintock C.S., Ramsey M.T., Peterson C.B. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop. Protein Sci. 2016; 25(2): 499-510.
- Iwaki T., Urano T., Umemura K. PAI-1, progress in understanding the clinical problem and its aetiology. Br. J. Haematol. 2012; 157(3): 291-8.
- Duffy M.J., McGowan P.M., Harbeck N., Thomssen C., Schmitt M. uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Res. 2014; 16(4): 428.
- Chen H., Peng H., Liu W., Sun Y., Su N., Tang W. et al. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis. Surgery. 2015; 158(6): 1704-13.
- Кит О.И., Франциянц Е.М., Козлова Л.С., Терпугов А.Л. Серпины в гиперпластических тканях толстой кишки. Экспериментальная и клиническая гастроэнтерология. 2014; (10): 18-21.
- Кит О.И., Франциянц Е.М., Никипелова Е.А., Комарова Е.Ф., Козлова Л.С., Таварин И.С. и др. Изменения маркеров пролиферации, неоангиогенеза и системы активации плазминогена в ткани рака прямой кишки. Экспериментальная и клиническая гастроэнтерология. 2015, 114(2): 40-5.
- Козлова Л.С., Франциянц Е.М., Атмачиди Д.П., Горбунова Т.А. Ингибиторы протеолиза в ликворе больных злокачественными глиомами после двух видов локальной интраоперационной химиотерапии. Злокачественные опухоли. 2014; 3: 15-7.
- Lindahl T.L., Ohlsson P.I., Wiman B. The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator. Biochem. J. 1990; 265(1): 109-13.
- Suzuki Y., Mogami H., Ihara H., Urano T. Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells. Blood. 2009; 113(2): 470-8.
- Suzuki Y., Urano T. Novel situations of endothelial injury in stroke-mechanisms of stroke and strategy of drug development: novel mechanism of the expression and amplification of cell surface-associated fibrinolytic activity demonstrated by real-time imaging analysis. J. Pharmacol. Sci. 2011; 116(1): 19-24.
- Niego B., Medcalf R.L. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis? J. Cereb. Blood Flow. Metab. 2014; 34(8): 1283-96.
- Schuliga M. The inflammatory actions of coagulant and fibrinolytic proteases in disease. Mediat. Inflamm. 2015; 2015: 437695. doi : 10.1155/2015/437695. Review.